In conclusion, the inhibition of ferroptosis caused by SLC7A11 up-regulation is very unfavorable for the treatment of lung cancer, but it also reflects its important regulatory role in the ferroptosis of lung cancer. This evidence concerns the gene SLC7A11 and lung carcinoma.